Jefferies Group’s Emergent Biosolutions EBS Stock Holding History

Jefferies Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,404	Closed	-$596K	–	2647
2019 Q3	$596K	Buy	+11,404	New	+$531K	﹤0.01%	1787
2018 Q3	–	Sell	-7,116	Closed	-$359K	–	2481
2018 Q2	$359K	Buy	7,116 +2,089	+42%	+$109K	﹤0.01%	1765
2018 Q1	$265K	Buy	+5,027	New	+$251K	﹤0.01%	1855
2017 Q4	–	Sell	-5,243	Closed	-$212K	–	2549
2017 Q3	$212K	Buy	+5,243	New	+$190K	﹤0.01%	2046
2017 Q2	–	Sell	-11,004	Closed	-$320K	–	2262
2017 Q1	$320K	Buy	+11,004	New	+$335K	﹤0.01%	1797
2015 Q4	–	Sell	-21,457	Closed	-$612K	–	2331
2015 Q3	$612K	Sell	21,457 -19,549	-48%	-$644K	﹤0.01%	1425
2015 Q2	$1.35M	Buy	+41,006	New	+$1.27M	0.01%	1109
2015 Q1	–	Sell	-10,057	Closed	-$274K	–	2161
2014 Q4	$274K	Buy	+10,057	New	+$240K	﹤0.01%	1588

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group's EBS Position: Q4 2019 in Review

Jefferies Group sold out of Emergent Biosolutions (EBS) in Q4 2019, closing a stake of 11,404 shares — an estimated $596K sold.

Jefferies Group first reported a position in EBS in Q4 2014 and held it in 8 quarters. The position peaked at $1.35M in Q2 2015. 236 funds tracked by Wall St. Rank hold EBS as of Q4 2019.

Jefferies Group reported no remaining Emergent Biosolutions position as of Q4 2019 after selling out during the quarter.
Jefferies Group sold 11,404 Emergent Biosolutions shares in Q4 2019, an estimated $596K.
Jefferies Group first reported a position in Emergent Biosolutions in Q4 2014 and held it in 8 quarters.
Jefferies Group's Emergent Biosolutions position peaked at $1.35M in Q2 2015.
236 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.